With the BD BBL™ Sensi-Disc™ portfolio, BD offers to laboratories an accurate, convenient, and broad disc diffusion solution that provides information to clinicians to help guide their treatment decisions.
1. Ahman J, et al., The quality of antimicrobial discs from nine manufacturers- EUCAST evaluations in 2014 and 2017, Clinical Microbiology and Infection(2018), https://doi.org/10.1016/j.cmi.2018.05.021.
Our collection of literature on industries and on our offerings gives you information you can use to continue striving for excellence.